Of the eight peptides that were monitored by MRM, one peptide, GGH.YYIAASYVK, showed very low signal-to-noise ratio of less than three in more than 50% of both the normal and NSCLC sera samples and the CV of two triplicate runs exceeded 30%. This evidence concerns the gene GGH and non-small cell lung carcinoma.